Mitigating Temozolomide Resistance in Glioblastoma via DNA Damage-Repair Inhibition
I. C. Sorribes, S. K. Handelman, H. V. Jain
This study develops a mechanistic model to identify optimal combination therapies for overcoming temozolomide resistance in glioblastoma by targeting DNA repair enzymes.
bioRxiv · Oct 5, 2019Cancer Biology